NO139169C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrerInfo
- Publication number
- NO139169C NO139169C NO1128/72A NO112872A NO139169C NO 139169 C NO139169 C NO 139169C NO 1128/72 A NO1128/72 A NO 1128/72A NO 112872 A NO112872 A NO 112872A NO 139169 C NO139169 C NO 139169C
- Authority
- NO
- Norway
- Prior art keywords
- aminoal
- trans
- hydroxy
- preparation
- therapeutically active
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7112668A FR2132570B1 (cs) | 1971-04-09 | 1971-04-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO139169B NO139169B (no) | 1978-10-09 |
NO139169C true NO139169C (no) | 1979-01-31 |
Family
ID=9075074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO1128/72A NO139169C (no) | 1971-04-09 | 1972-04-04 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer |
Country Status (26)
Country | Link |
---|---|
US (1) | US3828095A (cs) |
JP (1) | JPS5544738B1 (cs) |
AR (1) | AR192925A1 (cs) |
AT (1) | AT315151B (cs) |
AU (1) | AU463651B2 (cs) |
BE (1) | BE781805A (cs) |
BR (1) | BR7202015D0 (cs) |
CA (1) | CA999010A (cs) |
CH (1) | CH551942A (cs) |
CS (1) | CS171256B2 (cs) |
DD (1) | DD100459A5 (cs) |
DE (1) | DE2216537C2 (cs) |
ES (1) | ES401500A1 (cs) |
FR (1) | FR2132570B1 (cs) |
GB (1) | GB1358803A (cs) |
HU (1) | HU164931B (cs) |
IE (1) | IE36247B1 (cs) |
IL (1) | IL39147A (cs) |
IT (1) | IT998066B (cs) |
NL (1) | NL176453C (cs) |
NO (1) | NO139169C (cs) |
OA (1) | OA03987A (cs) |
SE (1) | SE385692B (cs) |
SU (1) | SU448639A3 (cs) |
YU (1) | YU35102B (cs) |
ZA (1) | ZA722318B (cs) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2623314C2 (de) * | 1976-05-25 | 1984-08-02 | Hoechst Ag, 6230 Frankfurt | 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
DE2818765A1 (de) * | 1978-04-28 | 1979-11-08 | Basf Ag | Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols |
NL7905218A (nl) * | 1978-07-05 | 1980-01-08 | Beiersdorf Ag | Gesubstitueerde 4-aryl-2.5-dihydro-furan-2-onen en 4-aryl-1.5-dihydro-2h-pyrrol-2-onen en werkwijzen voor de bereiding daarvan. |
EP0025331B1 (en) * | 1979-09-06 | 1983-03-02 | Beecham Group Plc | Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them |
SE8004088L (sv) * | 1980-06-02 | 1981-12-03 | Haessle Ab | Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ... |
SE8004087L (sv) | 1980-06-02 | 1981-12-03 | Haessle Ab | Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ... |
US4454154A (en) * | 1981-06-23 | 1984-06-12 | American Hospital Supply Corporation | Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents |
ZA827646B (en) * | 1981-11-12 | 1983-08-31 | American Hospital Supply Corp | Esters of aryloxypropanolamine derivatives |
US4508725A (en) * | 1982-12-22 | 1985-04-02 | American Hospital Supply Corporation | Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives |
US4593039A (en) * | 1984-04-02 | 1986-06-03 | Merck & Co., Inc. | 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols |
US5232948A (en) * | 1990-09-10 | 1993-08-03 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
WO2016203101A1 (en) | 2015-06-16 | 2016-12-22 | Axco-Motors Oy | Method and arrangement for adjusting the magnetization of a permanent magnet machine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3660230A (en) * | 1968-11-26 | 1972-05-02 | Gen Electric | Nuclear reactor control system |
CA945172A (en) * | 1969-02-21 | 1974-04-09 | Imperial Chemical Industries Limited | Alkanolamine derivatives |
-
1971
- 1971-04-09 FR FR7112668A patent/FR2132570B1/fr not_active Expired
-
1972
- 1972-03-23 YU YU771/72A patent/YU35102B/xx unknown
- 1972-03-29 OA OA54528A patent/OA03987A/xx unknown
- 1972-03-30 IE IE423/72A patent/IE36247B1/xx unknown
- 1972-04-04 NO NO1128/72A patent/NO139169C/no unknown
- 1972-04-04 SE SE7204266A patent/SE385692B/xx unknown
- 1972-04-05 US US00241381A patent/US3828095A/en not_active Expired - Lifetime
- 1972-04-06 CA CA139,108A patent/CA999010A/en not_active Expired
- 1972-04-06 IL IL39147A patent/IL39147A/en unknown
- 1972-04-06 GB GB1595072A patent/GB1358803A/en not_active Expired
- 1972-04-06 JP JP3396972A patent/JPS5544738B1/ja active Pending
- 1972-04-06 AU AU40818/72A patent/AU463651B2/en not_active Expired
- 1972-04-06 DE DE2216537A patent/DE2216537C2/de not_active Expired
- 1972-04-06 BR BR722015A patent/BR7202015D0/pt unknown
- 1972-04-06 CS CS2304A patent/CS171256B2/cs unknown
- 1972-04-06 ES ES401500A patent/ES401500A1/es not_active Expired
- 1972-04-07 BE BE116056A patent/BE781805A/xx not_active IP Right Cessation
- 1972-04-07 NL NLAANVRAGE7204726,A patent/NL176453C/xx not_active IP Right Cessation
- 1972-04-07 SU SU1772371A patent/SU448639A3/ru active
- 1972-04-07 CH CH516072A patent/CH551942A/fr not_active IP Right Cessation
- 1972-04-07 IT IT22835/72A patent/IT998066B/it active
- 1972-04-07 ZA ZA722318A patent/ZA722318B/xx unknown
- 1972-04-08 HU HULI227A patent/HU164931B/hu unknown
- 1972-04-10 AR AR241388A patent/AR192925A1/es active
- 1972-04-10 DD DD162185A patent/DD100459A5/xx unknown
- 1972-04-10 AT AT308272A patent/AT315151B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2132570A1 (cs) | 1972-11-24 |
BR7202015D0 (pt) | 1975-02-12 |
NL7204726A (cs) | 1972-10-11 |
NL176453B (nl) | 1984-11-16 |
JPS5544738B1 (cs) | 1980-11-13 |
OA03987A (fr) | 1979-09-15 |
DE2216537A1 (de) | 1972-10-19 |
AT315151B (de) | 1974-05-10 |
AR192925A1 (es) | 1973-03-21 |
US3828095A (en) | 1974-08-06 |
IE36247L (en) | 1972-10-09 |
IE36247B1 (en) | 1976-09-15 |
HU164931B (cs) | 1974-05-28 |
SU448639A3 (ru) | 1974-10-30 |
BE781805A (fr) | 1972-10-09 |
DE2216537C2 (de) | 1984-08-02 |
ZA722318B (en) | 1972-12-27 |
YU35102B (en) | 1980-09-25 |
CA999010A (en) | 1976-10-26 |
YU77172A (en) | 1980-03-15 |
GB1358803A (en) | 1974-07-03 |
CH551942A (fr) | 1974-07-31 |
SE385692B (sv) | 1976-07-19 |
AU4081872A (en) | 1973-10-11 |
FR2132570B1 (cs) | 1974-08-02 |
CS171256B2 (cs) | 1976-10-29 |
NO139169B (no) | 1978-10-09 |
AU463651B2 (en) | 1975-07-16 |
DD100459A5 (cs) | 1973-09-20 |
IT998066B (it) | 1976-01-20 |
IL39147A (en) | 1976-12-31 |
IL39147A0 (en) | 1972-06-28 |
ES401500A1 (es) | 1975-09-16 |
NL176453C (nl) | 1985-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO142441C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater | |
NO137440C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner | |
NO793013L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
NO140059C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater | |
NO137321C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive 3-okso-17alfa-acyloksyandrost-4-en-17beta-karboksylsyreestere | |
NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
NO139169C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer | |
NO140057C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater | |
NO140597C (no) | Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater | |
NO144153C (no) | Fremgangsmaate for fremstilling av delta3-7-acylamido-3-metyl-cefem-4-karboksylsyrer | |
NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
NO140821C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater | |
NO140670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater | |
NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
NO140824C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener | |
NO142260C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater | |
NO138561C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater | |
NO137999C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oxofurylestere av 6-(alfa-aminofenylacetamido)-penicillansyre | |
NO143499C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater | |
NO138285C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive lincomycinderivater | |
NO140299C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner | |
NO140007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive indolcarboxylsyrer | |
NO138947C (no) | Fremgangsmaate ved fremstilling av 2-alkoxy-5-alkylsulfonyl-benzoesyrer | |
NO138767C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive nitrosoureaderivater | |
NO140825C (no) | Analogifremgangmaate ved fremstilling av terapeutisk aktive pregnan-21-syrederivater |